glp 1 drugs and thyroid Glucagon-like peptide receptor agonist use risk of cancer: Scandinavian cohort study Ozempic: EU Sees No Evidence

A systematic search of PubMed, Scopus, and Web of Science was conducted up to December 2024 according to PRISMA guidelines

November 20, 2023

PLoS One 8 (4), e61965

[DOI] [PMC free article] [PubMed] [Google Scholar] 123.Peters A.L., Buschur E.O., Buse J.B., Cohan P., Diner J.C., Hirsch I.B

Alzheimers disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

Reported injuries in GLP-1 lawsuits range from chronic nausea and vomiting to intestinal obstruction, malnutrition, emergency surgery, and sudden vision loss, with symptom severity typically ranging from temporary digestive complications to permanent impairment